| Abstrakt: |
The article discusses the importance of accurately predicting survival in patients with metastatic bone disease to guide treatment decisions. Two survival prediction tools, SORG-MLA and METSSS, have been developed to improve outcomes for patients with long-bone metastases. The study validates SORG-MLA as a more effective tool for survival estimation and treatment decisions in Asian patients, emphasizing the need for further research and validation in clinical settings. The article highlights the importance of understanding and interpreting model results, as well as the challenges and opportunities in implementing predictive tools in healthcare. [Extracted from the article] |
